These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 7959522)

  • 1. [Paroxetine: pharmacokinetics and pharmacodynamics].
    Hiemke C
    Fortschr Neurol Psychiatr; 1994 Sep; 62 Suppl 1():2-8. PubMed ID: 7959522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacologic profile of paroxetine, a new selective serotonin reuptake inhibitor.
    Tulloch IF; Johnson AM
    J Clin Psychiatry; 1992 Feb; 53 Suppl():7-12. PubMed ID: 1531829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of cytochrome P4502D6 activity with paroxetine normalizes the ultrarapid metabolizer phenotype as measured by nortriptyline pharmacokinetics and the debrisoquin test.
    Laine K; Tybring G; Härtter S; Andersson K; Svensson JO; Widén J; Bertilsson L
    Clin Pharmacol Ther; 2001 Oct; 70(4):327-35. PubMed ID: 11673748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paroxetine: an overview of the efficacy and safety of a new selective serotonin reuptake inhibitor in the treatment of depression.
    Nemeroff CB
    J Clin Psychopharmacol; 1993 Dec; 13(6 Suppl 2):10S-17S. PubMed ID: 8106649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paroxetine: a pharmacological review.
    Johnson AM
    Int Clin Psychopharmacol; 1992 Jun; 6 Suppl 4():15-24. PubMed ID: 1331230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent pharmacologic advances in antidepressant therapy for the elderly.
    Preskorn SH
    Am J Med; 1993 May; 94(5A):2S-12S. PubMed ID: 8503477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paroxetine: a review.
    Bourin M; Chue P; Guillon Y
    CNS Drug Rev; 2001; 7(1):25-47. PubMed ID: 11420571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Introductory comments: a brief history of the development of paroxetine.
    Braestrup C
    Int Clin Psychopharmacol; 1992 Jun; 6 Suppl 4():1-3. PubMed ID: 1431006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immediate-release versus controlled-release formulations: pharmacokinetics of newer antidepressants in relation to nausea.
    DeVane CL
    J Clin Psychiatry; 2003; 64 Suppl 18():14-9. PubMed ID: 14700450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Managing rapid metabolizers of antidepressants.
    Kraus RP; Diaz P; McEachran A
    Depress Anxiety; 1996-1997; 4(6):320-7. PubMed ID: 9166660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical pharmacology and use of paroxetine, a new selective serotonin reuptake inhibitor.
    Nemeroff CB
    Pharmacotherapy; 1994; 14(2):127-38. PubMed ID: 8197030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Drug interactions and new antidepressive agents].
    Bonin B; Vandel S
    Therapie; 1995; 50(3):229-36. PubMed ID: 7667805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paroxetine. A review of its pharmacology, therapeutic use in depression and therapeutic potential in diabetic neuropathy.
    Holliday SM; Plosker GL
    Drugs Aging; 1993; 3(3):278-99. PubMed ID: 8324301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paroxetine: a review of its pharmacology, pharmacokinetics and utility in the treatment of a variety of psychiatric disorders.
    Heydorn WE
    Expert Opin Investig Drugs; 1999 Apr; 8(4):417-41. PubMed ID: 15992089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of the metabolism and pharmacokinetics of paroxetine in man.
    Kaye CM; Haddock RE; Langley PF; Mellows G; Tasker TC; Zussman BD; Greb WH
    Acta Psychiatr Scand Suppl; 1989; 350():60-75. PubMed ID: 2530793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of paroxetine, a selective serotonin reuptake inhibitor, in Grey parrots (Psittacus erithacus erithacus): influence of pharmaceutical formulation and length of dosing.
    van Zeeland YR; Schoemaker NJ; Haritova A; Smit JW; van Maarseveen EM; Lumeij JT; Fink-Gremmels J
    J Vet Pharmacol Ther; 2013 Feb; 36(1):51-8. PubMed ID: 22435778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paroxetine-The Antidepressant from Hell? Probably Not, But Caution Required.
    Nevels RM; Gontkovsky ST; Williams BE
    Psychopharmacol Bull; 2016 Mar; 46(1):77-104. PubMed ID: 27738376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of Paroxetine Molecular Interactions with Selected Monoamine and γ-Aminobutyric Acid Transporters.
    Kowalska M; Fijałkowski Ł; Nowaczyk A
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34208199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paroxetine hydrochloride.
    Germann D; Ma G; Han F; Tikhomirova A
    Profiles Drug Subst Excip Relat Methodol; 2013; 38():367-406. PubMed ID: 23668408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.